SQL & Python fundamentals
Focus on data manipulation, aggregations, and basic statistical analysis. Most questions are medium difficulty with emphasis on clean, readable code.
0 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Master the core skills that data analyst interviews actually test.. Explore key insights and preparation tips to help you excel in your interview process.
Focus on data manipulation, aggregations, and basic statistical analysis. Most questions are medium difficulty with emphasis on clean, readable code.
Design data warehouses, ETL processes, and reporting systems. Focus on scalability and data quality.
Data Warehousing
Star schema, dimensional modeling
ETL Pipelines
Batch processing, data validation
Reporting Systems
Dashboard design, performance optimization
Different companies emphasize different aspects of data analysis based on their business model and data maturity.
Meta
Product analytics, A/B testing, user behavior metrics
JPMorgan
Risk analytics, regulatory reporting, financial modeling
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 65% lower housing costs compared to San Francisco, with median home prices around $200K versus SF's $1.4M. Your data analyst salary stretches significantly further, enabling homeownership and substantial savings while maintaining access to major East Coast markets.
Baltimore's data analyst market shows healthy demand with manageable competition. Strong opportunities across healthcare, government contracting, and emerging fintech sectors.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States